313 related articles for article (PubMed ID: 19821719)
1. Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals.
Okamoto S; Hata A; Sadaoka K; Yamanishi K; Mori Y
J Infect Dis; 2009 Nov; 200(10):1606-10. PubMed ID: 19821719
[TBL] [Abstract][Full Text] [Related]
2. Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.
Sadaoka K; Okamoto S; Gomi Y; Tanimoto T; Ishikawa T; Yoshikawa T; Asano Y; Yamanishi K; Mori Y
J Infect Dis; 2008 Nov; 198(9):1327-33. PubMed ID: 18774884
[TBL] [Abstract][Full Text] [Related]
3. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
Berger R; Luescher D; Just M
Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
[TBL] [Abstract][Full Text] [Related]
4. Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.
Otani N; Yamanishi K; Sakaguchi Y; Imai Y; Shima M; Okuno T
J Immunol Methods; 2012 Mar; 377(1-2):53-5. PubMed ID: 22261191
[TBL] [Abstract][Full Text] [Related]
5. Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.
De Castro N; Carmagnat M; Kernéis S; Scieux C; Rabian C; Molina JM
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1089-97. PubMed ID: 21417759
[TBL] [Abstract][Full Text] [Related]
6. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
[TBL] [Abstract][Full Text] [Related]
7. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.
Weinberg A; Wiznia AA; LaFleur BJ; Shah S; Levin MJ
J Infect Dis; 2004 Jul; 190(2):267-70. PubMed ID: 15216460
[TBL] [Abstract][Full Text] [Related]
8. Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults.
Klein NP; Holmes TH; Sharp MA; Heineman TC; Schleiss MR; Bernstein DI; Kemble G; Arvin AM; Dekker CL
Vaccine; 2006 Aug; 24(33-34):5913-8. PubMed ID: 16759768
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
[TBL] [Abstract][Full Text] [Related]
10. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
11. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
12. Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization.
Smith JG; Levin M; Vessey R; Chan IS; Hayward AR; Liu X; Kaufhold RM; Clair J; Chalikonda I; Chan C; Bernard M; Wang WW; Keller P; Caulfield MJ
J Med Virol; 2003; 70 Suppl 1():S38-41. PubMed ID: 12627485
[TBL] [Abstract][Full Text] [Related]
13. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus.
Vossen MT; Gent MR; Weel JF; de Jong MD; van Lier RA; Kuijpers TW
J Infect Dis; 2004 Jul; 190(1):72-82. PubMed ID: 15195245
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity.
Otani N; Baba K; Okuno T
J Immunol Methods; 2009 Dec; 351(1-2):71-4. PubMed ID: 19818791
[TBL] [Abstract][Full Text] [Related]
15. Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus.
Hata A; Inoue F; Yamasaki M; Fujikawa J; Kawasaki Y; Hamamoto Y; Honjo S; Moriishi E; Mori Y; Koshiyama H
J Infect; 2013 Sep; 67(3):215-9. PubMed ID: 23603250
[TBL] [Abstract][Full Text] [Related]
16. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.
Asada H; Nagayama K; Okazaki A; Mori Y; Okuno Y; Takao Y; Miyazaki Y; Onishi F; Okeda M; Yano S; Kumihashi H; Gomi Y; Maeda K; Ishikawa T; Iso H; Yamanishi K;
J Dermatol Sci; 2013 Mar; 69(3):243-9. PubMed ID: 23183011
[TBL] [Abstract][Full Text] [Related]
17. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study.
Shirane R; Tang H; Hayashi K; Okuno Y; Iso H; Asada H; Yamanishi K; Mori Y;
J Med Virol; 2017 Feb; 89(2):313-317. PubMed ID: 27420414
[TBL] [Abstract][Full Text] [Related]
18. A community-based survey of varicella-zoster virus-specific immune responses in the elderly.
Tang H; Moriishi E; Okamoto S; Okuno Y; Iso H; Asada H; Yamanishi K; Mori Y;
J Clin Virol; 2012 Sep; 55(1):46-50. PubMed ID: 22771002
[TBL] [Abstract][Full Text] [Related]
19. Laboratory markers of immunity to varicella-zoster virus.
Zoulek G
Postgrad Med J; 1985; 61 Suppl 4():47-52. PubMed ID: 3014477
[TBL] [Abstract][Full Text] [Related]
20. Immune senescence and vaccines to prevent herpes zoster in older persons.
Levin MJ
Curr Opin Immunol; 2012 Aug; 24(4):494-500. PubMed ID: 22857823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]